VistaGen Therapeutics, Inc.
VTGN
$2.22
-$0.12-5.13%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -8.70% | -20.76% | -12.73% | -49.94% | 3.61% |
| Total Depreciation and Amortization | 2.55% | 3.97% | 3.07% | 2.45% | 2.88% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.62% | -14.81% | 115.89% | 4.24% | -13.18% |
| Change in Net Operating Assets | 182.24% | 166.25% | -186.58% | 73.06% | 393.23% |
| Cash from Operations | 5.57% | -0.16% | -51.02% | -51.61% | 23.31% |
| Capital Expenditure | 100.00% | -45.24% | -46.34% | 10.31% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 94.54% | -42.40% | -- | -- | -- |
| Cash from Investing | 94.58% | -42.42% | -18,948.78% | 10.31% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 0.00% | 100.13% |
| Issuance of Common Stock | -- | -100.00% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -203.07% |
| Cash from Financing | -- | -100.00% | 152.44% | -100.18% | 174.26% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 48.96% | -14.92% | -119.76% | -108.31% | 217.84% |